Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The northern california kaiser permanente diabetes registry

Diabetes Care

Volumn 24, Issue 7, 2001, Pages 1144-1150

  Ferrara, Assiamira ^a   Karter, Andrew J ^a   Ackerson, Lynn M ^a   Liu, Jennifer Y ^a   Selby, Joseph V ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; ASIAN AMERICAN; BLOOD; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; EDUCATIONAL STATUS; ESTROGEN THERAPY; ETHNIC GROUP; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH MAINTENANCE ORGANIZATION; HISPANIC; HUMAN; MEDICAL RECORD; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REGISTER; SMOKING; UNITED STATES;

AGED; ASIAN AMERICANS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; CALIFORNIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; ESTROGEN REPLACEMENT THERAPY; ETHNIC GROUPS; EXERCISE; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HUMANS; MEDICAL RECORDS; MIDDLE AGED; REGISTRIES; SMOKING;

EID: 0035403131     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.7.1144     Document Type: Article

References (14)

1. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR: Menopause and risk factors for coronary heart disease. N Engl J Med 321:641-646, 1989
2. Poehlman ET, Toth MJ, Gardner AW: Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123:673-675, 1995
3. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM: Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40:843-849, 1997
4. Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA, Bjorntorp P: Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:638-643, 1997
5. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208, 1995
6. Sattar N, Jaap AJ, MacCuish AC: Hormone replacement therapy and cardiovascular risk in post-menopausal women with NIDDM. Diabet Med 13:782-788, 1996
7. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: the Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 328: 1069-1075, 1993
8. Barrett-Connor E, Laakso M: Ischemic heart disease risk in postmenopausal women: effects of estrogen use on glucose and insulin levels. Arteriosclerosis 10:531-534, 1990
9. Ferrara A, Barrett-Connor E, Wingard DL, Edelstein SL: Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status: the Rancho Bernardo Study, 1984-1987. Diabetes Care 18:220-225, 1995
10. Salomaa V, Rasi V, Pekkanen J, Vahtera E, Jauhiainen M, Vartiainen E, Ehnholm C, Tuomilehto J, Myllyla G: Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors: the FINRISK Hemostasis Study. Arterioscler Thromb Vase Biol 15:1549-1555, 1995
11. Krieger N: Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82:703-710, 1992
12. Selby JV, Ray GT, Zhang D, Colby CJ: Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396-1402, 1997
13. Chang J, Hoke C, Ettinger B, Penerian G: Evaluation and interference study of hemoglobin Alc measured by turbidimetric inhibition immunoassay. Am J Clin Pathol 109:274-278, 1998
14. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986